Elevai Labs, Inc.—a medical aesthetic company specializing in physician-dispensed skincare products—closed its previously announced initial public offering of 1,500,000 shares of common stock at a public offering price of $4.00 per share for total gross proceeds of $6,000,000, before deducting underwriting discounts and other offering expenses. The shares of common stock began trading on the Nasdaq Capital Market on November 21, 2023, under the ticker symbol “ELAB.” The California...